Description
ARA 290 (Cibinetide) is a synthetic peptide derived from erythropoietin (EPO) that acts as an “innate repair receptor” (IRR) agonist, offering anti-inflammatory and tissue-protective effects without the typical side effects of EPO. It’s being studied for conditions like diabetic neuropathy, sarcoidosis, and diabetic macular edema (DMO) for its ability to reduce neuropathic pain, improve nerve density, and potentially reduce inflammation, acting as a potential novel pain reliever and tissue protector.
Reviews
There are no reviews yet.